These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28807821)

  • 1. POPDC1 is suppressed in human breast cancer tissues and is negatively regulated by EGFR in breast cancer cell lines.
    Amunjela JN; Tucker SJ
    Cancer Lett; 2017 Oct; 406():81-92. PubMed ID: 28807821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation.
    Amunjela JN; Tucker SJ
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28954821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves
    Gingold-Belfer R; Kessler-Icekson G; Morgenstern S; Rath-Wolfson L; Zemel R; Boltin D; Levi Z; Herman-Edelstein M
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POPDC proteins as potential novel therapeutic targets in cancer.
    Amunjela JN; Tucker SJ
    Drug Discov Today; 2016 Dec; 21(12):1920-1927. PubMed ID: 27458118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of the Popeye Domain Containing Gene Family in Organ Homeostasis.
    Amunjela JN; Swan AH; Brand T
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoferlin is a key regulator of EGFR activity in breast cancer.
    Turtoi A; Blomme A; Bellahcène A; Gilles C; Hennequière V; Peixoto P; Bianchi E; Noel A; De Pauw E; Lifrange E; Delvenne P; Castronovo V
    Cancer Res; 2013 Sep; 73(17):5438-48. PubMed ID: 23864327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
    Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
    IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new cancer stem cell markers and signaling pathways in HER‑2‑positive breast cancer by transcriptome sequencing.
    Feng L; Huang S; An G; Wang G; Gu S; Zhao X
    Int J Oncol; 2019 Nov; 55(5):1003-1018. PubMed ID: 31545416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Popeye domain-containing 1 is down-regulated in failing human hearts.
    Gingold-Belfer R; Bergman M; Alcalay Y; Schlesinger H; Aravot D; Berman M; Salman H; Brand T; Kessler-Icekson G
    Int J Mol Med; 2011 Jan; 27(1):25-31. PubMed ID: 21069264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High snail expression predicts a poor prognosis in breast invasive ductal carcinoma patients with HER2/EGFR-positive subtypes.
    Chang HY; Tseng YK; Chen YC; Shu CW; Lin MI; Liou HH; Fu TY; Lin YC; Ger LP; Yeh MH; Liu PF
    Surg Oncol; 2018 Jun; 27(2):314-320. PubMed ID: 29937187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
    Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
    World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.
    Bisaro B; Sciortino M; Colombo S; Camacho Leal MP; Costamagna A; Castellano I; Montemurro F; Rossi V; Valabrega G; Turco E; Defilippi P; Cabodi S
    Oncotarget; 2016 Jan; 7(4):4442-53. PubMed ID: 26716506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and epidermal growth factor receptor (EGFR) family expression.
    Badra FA; Karamouzis MV; Ravazoula P; Likaki-Karatza E; Tzorakoleftherakis E; Koukouras D; Iconomou G; Xiros N; Siablis D; Papavassiliou AG; Kalofonos HP
    Cancer Lett; 2006 Nov; 244(1):34-41. PubMed ID: 16517064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Clinical Significance of Sushi Domain- Containing Protein 3 (SUSD3) and Insulin-like Growth Factor-I Receptor (IGF-IR) in Breast Cancer.
    Zhao S; Chen SS; Gu Y; Jiang EZ; Yu ZH
    Asian Pac J Cancer Prev; 2015; 16(18):8633-6. PubMed ID: 26745129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients.
    He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G
    Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.
    Jin Y; Zhang W; Wang H; Zhang Z; Chu C; Liu X; Zou Q
    Oncol Rep; 2016 Feb; 35(2):771-8. PubMed ID: 26718028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
    Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
    Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer.
    Eggemann H; Ignatov T; Burger E; Kantelhardt EJ; Fettke F; Thomssen C; Costa SD; Ignatov A
    Endocr Relat Cancer; 2015 Oct; 22(5):725-33. PubMed ID: 26187126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.